GENERAL ATLANTIC, L.P.

Est. AUM

$2.15B

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	DLOCAL	CL A	$605.1M	46656695	28.17%	SOLE
2	CHIME	CL A	$398.2M	21259683	18.53%	SOLE
3	XP, INC	CL A	$391.6M	20566133	18.23%	SOLE
4	ALKAMI	COM	$240.3M	15337495	11.19%	SOLE
5	PHARVARIS	COM	$226.9M	8031252	10.56%	SOLE
6	EUROPEAN WAX CENTER	CL A	$75.8M	13110492	3.53%	SOLE
7	REVOLUTION MEDICINES	COM	$68.8M	707791	3.20%	SOLE
8	NURIX THERAPEUTICS	COM	$63.6M	4101865	2.96%	SOLE
9	CENTESSA PHARMACEUTICALS	ADS	$53.8M	1354830	2.50%	SOLE
10	RISKIFIED	CL A	$20.9M	5324998	0.97%	SOLE
11	GROVE COLLABORATIVE	CL A	$3.2M	2474859	0.15%	SOLE
12	WEBULL	ORD SHS	$244K	50816	0.01%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.